Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Gyeonggi-do
Clinical trial register · South Korea

Clinical Trials in Gyeonggi-do, 2026

Every study on the ClinicalTrials.gov registry that lists a site in South Korea and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3365 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:17 UTC
3365
Studies in scope
all four open statuses
1831
Recruiting now
open to new participants
500
Lead sponsors
across recruiting studies
Top sites
Seoul 71 Seongnam-si 24 Daegu 23 Gyeonggi-do 23 Goyang-si 19
Narrow the registerReset
Recruitment status
Phase
Site location
Seoul71 Seongnam-si24 Daegu23 Gyeonggi-do23 Goyang-si19
All 29 locations
Target enrolment
to

Trials with a site in Gyeonggi-do

23 of 3365 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in South Korea
Start
Recruiting
Hoffmann-La Roche
Phase 3
1,600
Seongnam-si, Daejeon, Gangwon-do, Gwangju, Gyeonggi-do, Seoul
2026-03-23
Recruiting
Hoffmann-La Roche
Phase 3
2,000
Daegu, Seongnam-si, Daejeon, Gwangju, Gyeonggi-do, Incheon, Seoul
2026-03-16
Recruiting
Hoffmann-La Roche
Phase 3
250
Daegu, Gyeonggi-do, Seoul
2025-11-27
Active, closed
Hoffmann-La Roche
Phase 3
1,060
Busan, Gwangju, Gyeonggi-do, Incheon, Seongnam-si, Seoul
2025-11-12
Recruiting
Hoffmann-La Roche
Phase 3
80,000
Gwangju, Gyeonggi-do, Incheon, Namdong-gu, Seongnam-si, Seoul, Suwon
2025-07-02
Active, closed
Hoffmann-La Roche
Phase 3
338
Gyeonggi-do, Incheon, Jeollanam-do, Seongnam-si, Seoul
2024-09-23
Active, closed
Hoffmann-La Roche
Phase 3
687
Goyang-si, Gyeonggi-do, Jeollanam-do, Seoul, Ulsan
2023-09-14
Active, closed
Hoffmann-La Roche
Phase 3
459
Anyang-si, Bucheon-si, Cheongju-si, Gyeonggi-do, Seongnam-si, Seoul
2023-08-08
Active, closed
Hoffmann-La Roche
Phase 3
2,000
Bucheon-si, Daegu, Gyeonggi-do, Incheon, Jeollabuk-do, Seoul, Wŏnju
2023-06-28
Recruiting
Hoffmann-La Roche
Phase 3
100
Goyang-si, Gyeonggi-do, Seongnam-si, Seoul
2023-06-01
Active, closed
Hoffmann-La Roche
Phase 3
1,290
Bucheon-si, Daegu, Gyeonggi-do, Seoul, Wŏnju
2022-12-29
Active, closed
Hoffmann-La Roche
Phase 3
4,170
Cheonan-si, Cheongju-si, Gangwon-do, Gyeonggi-do, Incheon, Namdong-Gu, Seongbuk-Gu, Seongnam
2021-08-27
Active, closed
Hoffmann-La Roche
Phase 3
557
Goyang-si, Gyeonggi-do, Seoul
2021-04-26
Active, closed
Hoffmann-La Roche
Phase 2
920
Gyeonggi-do, Seoul
2021-01-18
Active, closed
Hoffmann-La Roche
Phase 3
992
Cheongju-si, Daegu, Gyeonggi-do, Incheon, Seoul, Ulsan
2020-10-09
Active, closed
Hoffmann-La Roche
Phase 3
257
Gyeonggi-do, Incheon, Jeollanam-do, Seoul
2018-08-16
Active, closed
Hoffmann-La Roche
Phase 2/3
1,000
Gyeonggi-do, Jeollanam-do, Seoul
2017-09-22
Active, closed
Hoffmann-La Roche
Phase 3
382
Gyeonggi-do, Jeollanam-do, Seoul
2017-09-20
Rows per page Showing 1–23 of 23
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a South Korean investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 October 2026. https://priyalifescience.com/clinical-trials-south-korea/city/gyeonggi-do

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in South Korea and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,365 studies in total at the last sync on 11 Oct 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 23 of those studies with a site in Gyeonggi-do that also match the filters currently applied.

How many clinical trials are recruiting in Gyeonggi-do?

7 of the 23 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:17 UTC sync. A further 0 have not yet opened recruitment, 16 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Gyeonggi-do), 23 studies
PhaseStudiesRecruitingShare
Phase 317673.9%
Phase 2/33113%
Phase 2208.7%
Phase 1/2104.3%

Most active sponsors

Lead sponsors with the most studies (Gyeonggi-do)
Lead sponsorStudiesRecruiting
Hoffmann-La Roche237
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.